Orphan drugs

The so-called 'orphan drugs' are intended to treat diseases so rare that sponsors are reluctant to develop them under usual marketing conditions. The process from the invention of a replacement molecule to its marketing is long, expensive and really uncertain. Drugs that aren't developed by the pharmaceutical industry for economic reasons but which answer public health need. Actually, the indications of a drug can also be considered as ' orphan ' since a substance could also be utilized in the treatment of a frequent disease but might not are developed for an additional, more rare indication.


  • orphan drugs
  • pharmaceutical industry
  • Drugs
  • public health

Related Conference of Orphan drugs

July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Orphan drugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in